Literature DB >> 30576624

Pilot field trial of the EG95 vaccine against ovine cystic echinococcosis in Rio Negro, Argentina: 8 years of work.

Edmundo Larrieu1, Guillermo Mujica2, Daniel Araya2, Jose Luis Labanchi3, Marcos Arezo3, Eduardo Herrero2, Graciela Santillán4, Katherina Vizcaychipi4, Leonardo Uchiumi2, Juan Carlos Salvitti2, Claudia Grizmado2, Arnoldo Calabro2, Gabriel Talmon2, Luis Sepulveda2, Jose Maria Galvan2, Marta Cabrera4, Marcos Seleiman2, Pablo Crowley5, Graciela Cespedes4, Mariela García Cachau6, Lilia Gino6, Leonardo Molina6, Jose Daffner5, Charles G Gauci7, Meritxell Donadeu7, Marshall W Lightowlers7.   

Abstract

Cystic echinococcosis (CE) is endemic in the Rio Negro province of Argentina. After 30 years of control using praziquantel in dogs the transmission rate to humans and sheep has decreased significantly, however transmission persists. The objective of the study was to assess the inclusion of the EG95 for sheep in the control program and to determine the vaccine's operative feasibility in field conditions. An intervention study was defined in Rio Negro Province in Argentina comprising, in total, an area of 5820 Km2. Lambs received two vaccinations with the EG95 vaccine followed by a single booster injection when the animals were 1-1.5 years of age. Vaccination of lambs born into one trial site was introduced and continued for 8 years. Evidence for Echinococcus granulosus transmission was monitored before and after vaccination by coproantigen ELISA in faecal samples of dog, purgation of dogs to detect E. granulosus worms, necropsy on adult sheep and by ultrasound screening in children of 6-14 years old. 29,323 doses of vaccine were applied between 2009 and 2017, which a vaccination coverage of 80.1%/85.7% (57.3% average for fully vaccinated). Before the introduction of the vaccine 56.3% of the 6-year-old sheep were infected with E. granulosus at necropsy and 84.2% of the farms had infected sheep; 4.3% of the dogs were positive for E. granulosus infection using the arecoline test, and with coproELISA 9.6% of dog fecal samples were positive and 20.3% of the farms had infected dog.After the vaccine was introduced, 21.6% of sheep older than 6 years were found to be infected at necropsy and 20.2% of the farms were found to be infected; in dogs, 4.5% were found positive for E. granulosus using arecoline purgation and with coproELISA 3.7% of samples were positive, with 8.9% of farms having a positive dog. In 2016 only one case of E. granulosus infection was diagnosed by US screening in a 6-14 years old child. Included in the analysis are discussions of difficulties experienced in the field which affected correct vaccine administration as well as social features and practices that may impact on echinococcosis control and the EG95 vaccination program in Rio Negro. Vaccination of sheep with the EG95 vaccine provides a valuable new tool which improves the effectiveness of CE control activities. Vaccination was effective even in a difficult, remote environment where only approximately half the lambs born into the communities were fully vaccinated. Published by Elsevier B.V.

Entities:  

Keywords:  Control; Cystic echinococcosis; Diagnosis; EG95; Sheep; Vaccination

Mesh:

Substances:

Year:  2018        PMID: 30576624     DOI: 10.1016/j.actatropica.2018.12.025

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  6 in total

1.  Identification of B-cell dominant epitopes in the recombinant protein P29 from Echinococcus granulosus.

Authors:  Yongxue Lv; Shasha Li; Tingrui Zhang; Yazhou Zhu; Jia Tao; Jihui Yang; Liangliang Chang; Changyou Wu; Wei Zhao
Journal:  Immun Inflamm Dis       Date:  2022-05

2.  Identification of combined T-cell and B-cell reactive Echinococcus granulosus 95 antigens for the potential development of a multi-epitope vaccine.

Authors:  Liang Wang; Jian Gao; Xi Lan; Hui Zhao; Xiaoqian Shang; Fengming Tian; Hao Wen; Jianbing Ding; Li Luo; Xiumin Ma
Journal:  Ann Transl Med       Date:  2019-11

3.  Fast Focus Ultrasound Liver Technique for the Assessment of Cystic Echinococcosis in Sheep.

Authors:  Giuliano Borriello; Jacopo Guccione; Antonio Di Loria; Antonio Bosco; Paola Pepe; Francesco Prisco; Giuseppe Cringoli; Orlando Paciello; Laura Rinaldi; Paolo Ciaramella
Journal:  Animals (Basel)       Date:  2021-02-09       Impact factor: 2.752

4.  Echinococcoses in Iran, Turkey, and Pakistan: Old Diseases in the New Millennium.

Authors:  Mehdi Borhani; Saeid Fathi; Enayat Darabi; Fatemeh Jalousian; Sami Simsek; Haroon Ahmed; Harun Kaya Kesik; Seyed Hossein Hosseini; Thomas Romig; Majid Fasihi Harandi; Iraj Mobedi
Journal:  Clin Microbiol Rev       Date:  2021-06-02       Impact factor: 50.129

Review 5.  Use of Veterinary Vaccines for Livestock as a Strategy to Control Foodborne Parasitic Diseases.

Authors:  Valeria A Sander; Edwin F Sánchez López; Luisa Mendoza Morales; Victor A Ramos Duarte; Mariana G Corigliano; Marina Clemente
Journal:  Front Cell Infect Microbiol       Date:  2020-06-26       Impact factor: 5.293

6.  Assessment of the Vaccination Program against Cystic Echinococcosis in Sheep in the Pehuenche Community of Central Chile.

Authors:  Paula Gädicke; David Heath; Angela Medina-Brunet; María Carolina Siva-de la Fuente; Hellen Espinoza-Rojas; Carmen Villaguala-Pacheco; Makarena Rubilar; Carolina Cerda; Manuel Quezada; Daniela Rojas; AnaLía Henríquez; Marco Loyola; Carlos Landaeta-Aqueveque
Journal:  Animals (Basel)       Date:  2022-03-08       Impact factor: 2.752

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.